Global Infectious Diseases Diagnostics Market 2023: STDs to Remain Largest Segment; APAC Continues Dominance, Followed b

Comments · 100 Views

The global infectious diseases diagnostics market is predicted to expand at a CAGR of 7.0% over an eight-year forecast period, 2016-2024. The market will reach a value worth US$ 876.6 Mn by 2016 end, up from US$ 827.7 Mn attained in 2015. The revenues are expected to reach US$ 1503.8 Mn by

Infectious diseases diagnostics Market is a rapidly growing market, driven by the increasing prevalence of infectious diseases worldwide and the need for accurate and timely diagnosis to improve patient outcomes and control the spread of these diseases.

Request For Free Sample Report of “Infectious Diseases Diagnostics Market”@ https://www.persistencemarketresearch.com/samples/11413

One of the major drivers of this market is the increasing incidence of infectious diseases such as HIV, hepatitis, and tuberculosis. These diseases continue to pose a significant public health threat, particularly in developing countries, where access to diagnostic services is often limited.

Another key driver of the market is the growing demand for point-of-care (POC) diagnostic tests. POC tests are designed to be simple and easy to use, allowing healthcare providers to quickly and accurately diagnose patients at the point of care, rather than having to send samples to a laboratory for testing. This can greatly improve patient outcomes, as well as reduce the spread of infectious diseases by allowing for earlier diagnosis and treatment.

Companies

  • Becton Dickinson Company
  • Cepheid, Inc.
  • Abbott Laboratories
  • bioMerieux SA
  • Hologic, Inc.
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.
  • Roche Diagnostics
  • Alera Inc.
  • DiaSorin S.p.A.
  • Quidel Corporation
  • Bio-Rad Laboratories, Inc.

 Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/11413

Geographically, the rheumatoid arthritis treatment market is segmented into North America, The market is also being driven by advances in technology, such as the development of new diagnostic assays and platforms that are more sensitive and specific than traditional methods. For example, newer assays, such as PCR-based tests and next-generation sequencing (NGS) have greatly improved the detection of infectious diseases such as HIV and hepatitis.

The market is segmented on the basis of technology, application, and end-user. On the basis of technology, the market is segmented into conventional diagnostic methods, such as culture and serology, and molecular diagnostic methods, such as PCR and NGS. On the basis of application, the market is segmented into respiratory, blood borne, sexually transmitted, and others. On the basis of end-user, the market is segmented into hospitals, diagnostic laboratories, research and academic institutes, and others.

Overall, the infectious diseases diagnostics market is expected to grow at a significant rate during the forecast period, driven by the increasing prevalence of infectious diseases and the growing demand for POC diagnostic tests. However, the market is also facing some challenges, such as the high cost of diagnostic tests, and the lack of access to diagnostic services in developing countries.

Regional Analysis

Based on the regional analysis, the global infectious disease diagnostics market is segmented into five key regions, North America (the U.S. and Canada), Latin America (Brazil, Mexico, and rest of Latin America), Europe (France, Germany, Italy, Spain, the U.K., Russia, and rest of Europe), Asia Pacific (China, India, Japan, Australia, New Zealand, ASEAN, and rest of APAC), and Middle East Africa (GCC countries, South Africa, and rest of MEA). APAC and MEA are foreseen to remain the major markets throughout the forecast period.

Request Customization @ https://www.persistencemarketresearch.com/request-customization/11413

- Table of Content –

 

  1. Executive Summary

 

  1. Assumptions and Acronyms

 

  1. Research Methodology

 

  1. Infectious Disease Diagnostics Market Overview

 

    4.1. Introduction

 

        4.1.1. Infectious Disease Diagnostics Market Definition

 

        4.1.2. Infectious Disease Diagnostics Market Taxonomy

 

    4.2. Infectious Disease Diagnostics Market Dynamics

 

        4.2.1. Drivers

 

        4.2.2. Restraints

 

        4.2.3. Opportunities

 

        4.2.4. Trends

 

  1. Global Infectious Disease Diagnostics Market Analysis, By Disease Indication

 For More Premium Insights, Check out the Link:

Libya Dialysis Machines market

OTC Scar Treatment market

High Flow Oxygen Therapy Devices market

Bioinks market

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

Contact Us:

Persistence Market Research

Japan

Persistence Market Research

1-2-1 Kinshi Arca Central Building 14/F Tokyo, 130-0013 Japan

Call 0800-222-1088

United States

Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States

U.S. Ph. – +1-646-568-7751

USA-Canada Toll-free – +1 800-961-0353

Sales – sales@persistencemarketresearch.com

Read more
Comments